Knowledge Center

MannKind Fact Sheets:

Product Pipeline Fact Sheets:

• MannKind Corporation
• Alfred E. Mann
• Diabetes

• Diabetes: AFREZZA

Inhalation Technologies
Fact Sheets:

Published Articles:

• Dry Powder Delivery Platform
• Inhalers

• AFREZZA Publications (bibliography)
• Prandial Insulin: Is Inhaled Enough?
• Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes
• Evaluation of novel particles as an inhalation system for GLP-1
• Innovation in Drug Delivery by Inhalation

Monographs:

• Postprandial Hyperglycemia: Clinical Significance, Pathogenesis and Treatment

Data Presentations:

• Scientific Meetings
• Diabetes
• American Diabetes Association (ADA) 2011
• American Diabetes Association (ADA) 2010
• American Diabetes Association (ADA) 2009
• Inhaled GLP-1 and Exenatide: Different Effects on Pancreatic and Gastric Activity
• Pulmonary Administration of GLP 1 Technosphere Powder Elicits Dose dependent Insulin Response
• American Academy of Clinical Endocrinologists (AACE) 2010
• Diabetes Technology Society (DTS) 2010
• European Association for the Study of Diabetes (EASD) 2009
• European Association for the Study of Diabetes (EASD) 2008
• Pulmonary administration of GLP1: Kinetics
• Pulmonary administration of GLP1: Kinetics 
• Oncology
• American Society of Clinical Oncologists (ASCO) 2010
• American Association of Cancer Research (AACR) 2010
• American Association of Cancer Research (AACR) 2009
• International Society for Biological Therapy of Cancer (iSBTc) 2009
• Other
• Neurogastroenterology and Motility (NGM) 2009
• Device Bioequivalence Data - MKC 142
• Technosphere QT study